4.6 Article

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges-2023 update

期刊

GYNECOLOGIC ONCOLOGY
卷 173, 期 -, 页码 58-67

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2023.04.009

关键词

Enhanced recovery after surgery; ERAS; Perioperative care; Surgical quality; Gynecologic oncology surgery

向作者/读者索取更多资源

This article presents the updated evidence and recommendations for implementing Enhanced Recovery After Surgery (ERAS) in gynecologic oncology surgery. It focuses on addressing implementation challenges and provides evidence-based guidelines.
Background. Despite evidence supporting its use, many Enhanced Recovery After Surgery (ERAS) recommen-dations remain poorly adhered to and barriers to ERAS implementation persist. In this second updated ERAS (R) Society guideline, a consensus for optimal perioperative care in gynecologic oncology surgery is presented, with a specific emphasis on implementation challenges.Methods. Based on the gaps identified by clinician stakeholder groups, nine implementation challenge topics were prioritized for review. A database search of publications using Embase and PubMed was performed (2018-2023). Studies on each topic were selected with emphasis on meta-analyses, randomized controlled trials, and large prospective cohort studies. These studies were then reviewed and graded by an international panel according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system.Results. All recommendations on ERAS implementation challenge topics are based on best available evidence. The level of evidence for each item is presented accordingly.Conclusions. The updated evidence base and recommendations for stakeholder derived ERAS implementation challenges in gynecologic oncology are presented by the ERAS (R) Society in this consensus review.(c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Eun-Young Kang, Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Adelyn Bolithon, Gordana Popovic, Betty Leung, Katrina Tang, Neil Lambie, Joshua Millstein, Jennifer Alsop, Michael S. Anglesio, Beyhan Ataseven, Ellen Barlow, Matthias W. Beckmann, Jessica Berger, Christiani Bisinotto, Hans Boesmueller, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Sara Y. Brucker, Michael E. Carney, Yovanni Casablanca, Alicia Cazorla-Jimenez, Paul A. Cohen, Thomas P. Conrads, Linda S. Cook, Penny Coulson, Madeleine Courtney-Brooks, Daniel W. Cramer, Philip Crowe, Julie M. Cunningham, Cezary Cybulski, Kathleen M. Darcy, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Rhonda Farrell, Sian Fereday, Anna Fischer, Maria J. Garcia, Simon A. Gayther, Aleksandra Gentry-Maharaj, C. Blake Gilks, Marcel Grube, Paul R. Harnett, Shariska Petersen Harrington, Philipp Harter, Arndt Hartmann, Jonathan L. Hecht, Sebastian Heikaus, Alexander Hein, Florian Heitz, Joy Hendley, Brenda Y. Hernandez, Susanna Hernando Polo, Sabine Heublein, Akira Hirasawa, Estrid Hogdall, Claus K. Hogdall, Hugo M. Horlings, David G. Huntsman, Tomasz Huzarski, Andrea Jewell, Mercedes Jimenez-Linan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Dineo Khabele, Felix K. F. Kommoss, Roy F. P. M. Kruitwagen, Diether Lambrechts, Nhu D. Le, Marcin Lener, Jenny Lester, Yee Leung, Anna Linder, Liselore Loverix, Jan Lubinski, Rashna Madan, G. Larry Maxwell, Francesmary Modugno, Susan L. Neuhausen, Alexander Olawaiye, Siel Olbrecht, Sandra Orsulic, Jose Palacios, Celeste Leigh Pearce, Malcolm C. Pike, Carmel M. Quinn, Ganendra Raj Mohan, Cristina Rodriguez-Antona, Matthias Ruebner, Andy Ryan, Stuart G. Salfinger, Naoko Sasamoto, Joellen M. Schildkraut, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Yurii B. Shvetsov, Naveena Singh, Gabe S. Sonke, Linda Steele, Colin J. R. Stewart, Karin Sundfeldt, Anthony J. Swerdlow, Aline Talhouk, Adeline Tan, Sarah E. Taylor, Kathryn L. Terry, Aleksandra Toloczko, Nadia Traficante, Koen K. Van de Vijver, Maaike A. van der Aa, Toon Van Gorp, Els Van Nieuwenhuysen, Lilian Van-Wagensveld, Ignace Vergote, Robert A. Vierkant, Chen Wang, Lynne R. Wilkens, Stacey J. Winham, Anna H. Wu, Javier Benitez, Andrew Berchuck, Francisco J. Candido Dos Reis, Anna DeFazio, Peter A. Fasching, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, Beth Y. Karlan, Stefan Kommoss, Usha Menon, Hans-Peter Sinn, Annette Staebler, James D. Brenton, David D. Bowtell, Paul D. P. Pharoah, Susan J. Ramus, Martin Kobel

Summary: This study validates that high-level amplification of CCNE1 is associated with shorter survival in tubo-ovarian high-grade serous carcinoma (HGSC), supporting its use as a prognostic biomarker in this disease.

CANCER (2023)

Article Oncology

Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study

Citadel J. J. Cabasag, Melina Arnold, Mark Rutherford, Jacques Ferlay, Aude Bardot, Eileen Morgan, John Butler, Dianne L. L. O'Connell, Gregg Nelson, Claus Hogdall, Tine Schnack, Anna Gavin, Mark Elwood, Louise Hanna, Charlie Gourley, Prithwish De, Nathalie Saint-Jacques, Lina Steinrud Morch, Ryan R. Woods, Alon D. D. Altman, Peter Sykes, Paul A. A. Cohen, Orla McNally, Bjorn Moller, Paul Walsh, David S. S. Morrison, Freddie Bray, Isabelle Soerjomataram

Summary: The aim of this study was to assess the incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high-income countries. Data from 1995 to 2014 were obtained from 20 cancer registries, and results showed that there was a significant increase in serous carcinoma incidence among women aged 65 to 99 years. On the other hand, the incidence of adenocarcinoma not otherwise specified showed a marked decrease in women aged 15 to 64 years. The overall survival of EOC has improved over the 20-year study period in all countries.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

A comparison of synoptic reports and dictated reports to enhance and standardize surgical documentation and quality of care in epithelial ovarian cancer

Jenna Shirley, Pascal Lambert, Mark W. Nachtigal, Alon D. Altman

Summary: This study assesses the documentation of elements in the OCPCDE checklist in synoptic reports (SRs) and dictated reports (DRs) for suspected epithelial ovarian cancer surgery. The SRs were found to include more data elements, indicating their completeness and importance. It is recommended to continue using SRs in our department and implement synoptic reporting in other gynecologic oncology centers.

GYNECOLOGIC ONCOLOGY (2023)

Article Genetics & Heredity

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods study

Selina Casalino, Sharon Bruce, Kim Serfas, Alon D. Altman, Sarah Kean, Pascal Lambert, Kirk J. McManus, Jessica N. Hartley, Mark W. Nachtigal

Summary: Individuals with pathogenic variants in BRCA1 or BRCA2 have an increased risk of developing high-grade serous ovarian cancer. Risk-reducing salpingo-oophorectomy (RRSO) is recommended for these individuals to preventatively remove their ovaries and fallopian tubes. The Hereditary Gynecology Clinic (HGC) in Winnipeg, Canada provides specialized care for BRCA-positive individuals. A study was conducted to explore the decision-making processes and experiences of these individuals at the HGC. The study found that the HGC played a supporting role in decision-making, and a novel framework was proposed to consolidate the various influences and implications of RRSO in the context of the HGC.

JOURNAL OF GENETIC COUNSELING (2023)

Review Surgery

Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting

Tamir N. Sholklapper, Jorge Ballon, Aref S. Sayegh, Anibal La Riva, Laura C. Perez, Sherry Huang, Michael Eppler, Gregg Nelson, Giovanni Marchegiani, Robert Hinchliffe, Luca Gordini, Marc Furrer, Michael J. Brenner, Salome Dell-Kuster, Chandra Shekhar Biyani, Nader Francis, Haytham M. A. Kaafarani, Matthias Siepe, Des Winter, Julie A. Sosa, Francesco Bandello, Robert Siemens, Jochen Walz, Alberto Briganti, Christian Gratzke, Andre L. Abreu, Mihir M. Desai, Rene Sotelo, Riaz Agha, Keith D. Lillemoe, Steven Wexner, Gary S. Collins, Inderbir Gill, Giovanni E. Cacciamani

Summary: This study assesses the prevalence and typology of perioperative adverse event reporting guidelines among surgery and anesthesiology journals. Results show that 46.5% of the queried journals recommend surgical adverse event reporting. Journals in the surgery, urology, and anesthesia categories are most likely to recommend reporting; those in the top SJR quartiles and based in Western Europe, North America, and the Middle East are also more likely to recommend.

INTERNATIONAL JOURNAL OF SURGERY (2023)

Article Surgery

Effect of Smartphone App Postoperative Home Monitoring After Oncologic Surgery on Quality of Recovery A Randomized Clinical Trial

Claire Temple-Oberle, Spencer Yakaback, Carmen Webb, Golpira Elmi Assadzadeh, Gregg Nelson

Summary: This randomized clinical trial compared the quality of recovery and patient satisfaction between conventional in-person follow-up and smartphone app-assisted follow-up for patients undergoing breast reconstruction and gynecologic oncology surgery. The results showed that smartphone app-assisted follow-up led to improved quality of recovery compared to conventional in-person follow-up, with equal patient satisfaction.

JAMA SURGERY (2023)

Article Oncology

Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study

Sabrina Piedimonte, Limor Helpman, Gregory Pond, Gregg Nelson, Janice Kwon, Alon Altman, Tomer Feigenberg, Laurie Elit, Susie Lau, Jeanelle Sabourin, Vanessa Samouelian, Karla Willows, Christa Aubrey, Ji-Hyun Jang, Ly-Ann Teo -Fortin, Norah Cockburn, Nora -Beth Saunders, Sarah Shamiya, Danielle Vicus, Marie Plante

Summary: This study aimed to determine whether close and positive surgical margins are associated with surgical approach and survival. The results showed that the surgical approach was not associated with margin status, but close margins were associated with a higher risk of death. Minimally invasive surgery was also associated with worse survival, suggesting that margin status may not be the main driver of worse survival in these cases.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery

Cristina Mitric, Sarah Daisy Kosa, Soyoun Rachel Kim, Gregg Nelson, Stephane Laframboise, Genevieve Bouchard-Fortier

Summary: The implementation of a peri-operative care program based on enhanced recovery after surgery principles for minimally invasive gynecologic oncology surgery led to an improvement in same day discharge rate and significant reductions in overall costs and some surgical and post-operative visit costs.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort study

Anastasios Pandraklakis, Dimitrios Haidopoulos, Theodoros Lappas, Emmanouil Stamatakis, Dimitrios Valsamidis, Maria D. Oikonomou, Dimitrios Loutradis, Alexandros Rodolakis, Steven P. Bisch, Gregg Nelson, Nikolaos Thomakos

Summary: This study evaluated the safety and effectiveness of thoracic epidural analgesia in gynecologic oncology patients undergoing laparotomy as part of the enhanced recovery after surgery (ERAS) multimodal analgesic protocol. The results showed that thoracic epidural analgesia provided better pain relief and additional benefits during the peri-operative period, improving the overall recovery experience of patients with gynecologic cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Review Oncology

Current Oncology Reports: Enhanced Recovery in Gynecologic Oncology Surgery-State of the Science

Gregg Nelson

Summary: The purpose of this review is to provide an overview of the current state of research on enhanced recovery after surgery (ERAS) in gynecologic oncology. Over the past 5 years, there has been increasing evidence supporting the use of ERAS in gynecologic oncology surgery. However, surveys have shown that ERAS uptake is not optimal, and implementing ERAS can be challenging. This review discusses the core components necessary for successful ERAS implementation, as well as specific developments in gynecologic oncology, such as same-day discharge initiatives and the use of telemedicine.

CURRENT ONCOLOGY REPORTS (2023)

Article Oncology

Discontinuation of mechanical bowel preparation in advanced ovarian cancer surgery: an enhanced recovery after surgery (ERAS) initiative

Jose Luis Sanchez-Iglesias, Natalia R. Gomez-Hidalgo, Vicente Bebia, Jose Manuel Ramirez, Asuncion Perez-Benavente, Gregg Nelson, Antonio Gil-Moreno

Summary: A retrospective study found that mechanical bowel preparation (MBP) was not associated with any specific benefit for advanced ovarian cancer surgery, and it is recommended for gynecologic oncologists to consider discontinuing this practice.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

Article Oncology

Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study

Christa Aubrey, Gregory R. Pond, Limor Helpman, Danielle Vicus, Laurie Elit, Marie Plante, Susie Lau, Janice S. Kwon, Alon D. Altman, Karla Willows, Tomer Feigenberg, Jeanelle Sabourin, Vanessa Samouelian, Laurence Bernard, Norah Cockburn, Nora-Beth Saunders, Sabrina Piedimonte, Ly-Ann Teo-Fortin, Soyoun Rachel Kim, Noor Sadeq, Ji-Hyun Jang, Sarah Shamiya, Gregg Nelson

Summary: Minimally invasive surgery for macroscopic cervical cancer leads to worse outcomes than open surgery, but preoperative conization may help mitigate the risk. This retrospective study examined oncologic outcomes in cervical cancer cases treated initially with conization and subsequent hysterectomy using either minimally invasive or open approaches. The study found no significant differences in recurrence-free survival or overall survival between the two surgical approaches. However, further studies are needed to confirm these findings.

CURRENT ONCOLOGY (2023)

Letter Anesthesiology

Analgesic efficacy of surgeon-administered transversus abdominis plane blocks for Cesarean delivery: a systematic review

Sylvie Bowden, Gabrielle Wagner, Cindy Xue, Gregg Nelson, Amy Metcalfe

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2023)

Article Oncology

Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions

Dimitrios Nasioudis, Stefan Gysler, Nawar Latif, Lory Cory, Robert L. Giuntoli II, Sarah H. Kim, Fiona Simpkins, Lainie Martin, Emily M. Ko

Summary: The prevalence of ERBB2 gene amplification was investigated among patients with gynecologic malignancies. The study found that ERBB2 amplification is frequently encountered in uterine serous carcinoma and mucinous ovarian carcinoma, but less common in endometrioid endometrial carcinoma.

GYNECOLOGIC ONCOLOGY (2024)